China CAS:57-83-0 Manufacturer

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for CAS:57-83-0, With our rules of " small business track record, partner trust and mutual benefit", welcome all of you to definitely work together , expand with each other.
CAS:57-83-0, Our aim is to help customers realize their goals. We have been making great efforts to achieve this win-win situation and sincerely welcome you to join us. In a word, when you choose us, you choose a perfect life. Welcome to visit our factory and welcome your order! For further inquiries, remember to do not hesitate to contact us.

Hot Products

  • Desonide

    Desonide

    Desonide has USP and EP specifications. DMF available.

    CAS:638-94-8

  • DHEA (Prasterone)

    DHEA (Prasterone)

    DHEA (Prasterone) has FP and In-house specification. DMF and WC available.

    CAS:53-43-0

  • Estriol

    Estriol

    Estriol has CP, EP, USP specifications. DMF under filing.

    CAS:50-27-1

  • 16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA)

    16-Dehydropregnenolone Acetate (16-DPA) is the dehydration product of Pregnenolone Acetate..

    CAS:979-02-2

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • 4-aza-5α-androstan-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-3-oxo-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:104239-97-6

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept